Globus Medical Reports Second Quarter 2024 Results

AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2024. Worldwide net sales were 31.8 million GAAP diluted earnings per share ("EPS") was 0.75 Non-GAAP adjusted EBITDA was $190.4 million, or 30.2% of net sales "I'm ...